Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +1.89% | +45.45% | -13.60% |
Financials (USD)
Sales 2024 * | 6.74M | Sales 2025 * | 3.27M | Capitalization | 63.7M |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -85M | EV / Sales 2024 * | 1.82 x |
Net cash position 2024 * | 51.41M | Net Debt 2025 * | 28.09M | EV / Sales 2025 * | 28.1 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-0.72
x | Employees | 61 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.05% |
Latest transcript on Kronos Bio, Inc.
1 day | +1.89% | ||
1 week | +48.56% | ||
Current month | +36.71% | ||
1 month | +5.88% | ||
3 months | -7.30% | ||
6 months | -21.74% | ||
Current year | -13.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 18-03-31 | |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
David Tanen
FOU | Founder | 52 | 17-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Tanen
FOU | Founder | 52 | 17-06-01 |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
Arie Belldegrun
FOU | Founder | 74 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 1.08 | +1.89% | 538,046 |
24-06-13 | 1.06 | -17.19% | 1,936,672 |
24-06-12 | 1.28 | +11.30% | 2,123,537 |
24-06-11 | 1.15 | +20.93% | 1,616,260 |
24-06-10 | 0.951 | +28.08% | 2,801,370 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.60% | 63.7M | |
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- KRON Stock